SCHEMBL29933299

SCHEMBL29933299

Cc1cccc(OC(C)C)c1C(=O)CBr

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.41
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
ALDH1A1 P00352 2/20 0.40
ACHE P22303 1/20 0.40
KDM4E B2RXH2 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
LMNA P02545 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
TAS1R2 Q8TE23 1/20 0.36
EZH2 Q15910 2/20 0.36
GSK3B P49841 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
PDE4B Q07343 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23364831 1.00 IRAK4 (0.41) IRAK4IDO1TDO2ALDH1A1ACHE
SCHEMBL23380055 0.84 IRAK4 (0.41) IRAK4IDO1TDO2ALDH1A1ACHE
SCHEMBL16921588 0.82 CA12 (0.52) ALDH1A1KDM4ELMNACA1CA2
SCHEMBL23364836 0.80 CA1 (0.48) IRAK4ALDH1A1ACHEKDM4ETDP1
SCHEMBL23364568 0.80 IRAK4 (0.46) IRAK4IDO1TDO2ALDH1A1ACHE
SCHEMBL29932864 0.80 IRAK4 (0.46) IRAK4IDO1TDO2ALDH1A1ACHE
SCHEMBL5725592 0.79 GSK3B (0.48) ALDH1A1KDM4ETDP1LMNAGSK3B
SCHEMBL28020118 0.78 CA12 (0.53) IRAK4ALDH1A1KDM4ETDP1LMNA
SCHEMBL23364634 0.78 CA1 (0.56) IRAK4ALDH1A1ACHEKDM4ETDP1
SCHEMBL11442930 0.76 IRAK4 (0.62) IRAK4IDO1TDO2ALDH1A1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4058439-A1 5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY Genzyme Corporation (US) 2022-09-21 EP disclosed
CN-115003659-A 5-membered heteroaryl amino sulfonamides for the treatment of conditions mediated by a deficiency in CFTR activity 健赞公司 2022-09-02 CN disclosed